Diabetic retinopathy
Diabetic retinopathy. Diabetic retinopathy (DR) is a disease whose screening actually can change the functional prognosis for the patients. It makes blindness avoidable. Annual screening using funduscopy or retinography for all diabetic patients is mandatory and yet not sufficiently and systematically performed in France. French Public health authority is developping telemedicine screening programs in different french regions to improve the prevention of DR. The treatment of DR is based on the management of its 2 major complications, that can coexist: preretinal neovascular proliferation (proliferative diabetic retinopathy), and diabetic macular edema (DME). Both of these complications require preventive management through strict control of blood glucose, blood pressure and hyperlipidemia. Once the complication is present, PRP must be performed to treat the neovessels while antiVEGF or corticosteroids intravitreal injections are the best way to treat DME. Surgery is required for more complicated forms of DR, such as intra-vitreous haemorrhage, retinal detachment, or neovascular glaucoma.